December 26, 2025
The simulators market size is forecast to increase from USD 14.72 billion in 2026 to USD 25.53 billion by 2034...
Read MoreDecember 26, 2025
The anti-aging market size is forecast to grow from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 02, 2026
According to market projections, the respiratory infections antibiotics market was valued at USD 10.83 billion in 2026 and is projected to reach USD 17.01 billion by 2035, growing at a CAGR of 5.14%. The report delivers in-depth analysis across antibiotic class, route of administration, indication, healthcare setting, and regions including North Am...
December 30, 2025
Based on market forecasts, the global drug repurposing market, projected at USD 636.95 million in 2025, is expected to reach USD 2506.64 million by 2035, growing at a CAGR of 14.76% over the forecast period. The world is demanding faster, more affordable alternatives for the traditional drug development process. North America registered dominance w...
December 30, 2025
According to market projections, the sulfonamides market was valued at USD 1.91 billion in 2025 and is projected to grow from USD 1.97 billion in 2026 to USD 2.7 billion by 2035, registering a CAGR of 3.54% during the forecast period. The sulfonamides market report provides detailed coverage of product types, applications, routes of administration,...
December 29, 2025
The therapeutic neurotoxin market was valued at USD 6.39 billion in 2025 and is projected to reach USD 6.94 billion in 2026, expanding to approximately USD 14.5 billion by 2035 at a CAGR of 8.54% 2026 to 2035. The report covers detailed segment analysis by neurotoxin type, end users, and route of administration....
December 26, 2025
According to forecasts, the U.S. compounding pharmacy market will grow from USD 6.57 billion in 2024 to USD 12.02 billion by 2034, with an expected CAGR of 6.24%. The rising incidence of chronic conditions like diabetes, arthritis, and cancer necessitates ongoing treatment regimens. Compounded medications offer flexibility in dosing and formulation...
December 26, 2025
The market is growing due to the rising prevalence of atopic diseases like dermatitis and asthma, coupled with increasing demand for advanced biologically targeted therapies. Growing awareness, better diagnostics, and expanding healthcare access are also fueling market expansion....
December 26, 2025
According to forecasts, the global anti-aging market will grow from USD 75.78 billion in 2024 to USD 129.88 billion by 2034, with an expected CAGR of 5.54%. The market is growing due to rising consumer focus on health, wellness, and youthful appearance. Advances in skincare, supplements, and cosmetic treatments are also driving higher adoption in N...
December 26, 2025
The global cell and gene therapy GMP drug substance market was USD 0.74 billion in 2024 and is projected to reach USD 1.64 billion by 2034 at a CAGR of 8.2%. Key segments include viral vectors, cell-based therapies, oligonucleotides, and biologics. North America leads, with Asia-Pacific growing fastest. The market features top players like AGC Bi...
December 26, 2025
The emerging need for oral medicines is due to the progression of diabetes, inadequate lifestyle management, and declining insulin production. North America dominated the market in 2024, driven by the growing aging population, innovative drug treatments, and improved access and affordability....
December 16, 2025
According to market projections, small molecule inhibitor market was valued at USD 310.38 billion in 2025 and is expected to reach USD 328.22 billion by 2026, further expanding to around USD 542.87 billion by 2035, growing at a CAGR of 5.75% from 2026 to 2035....